SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study
Sachin Dhumal(Homi Bhabha National Institute), Sudeep Gupta(Homi Bhabha National Institute), Amar Patil(Tata Memorial Hospital), Meera Sharad Achrekar(Tata Memorial Hospital), Atanu Bhattacharjee, Prasanth Bhat(Tata Memorial Hospital), Bhakti Trivedi(Homi Bhabha National Institute), Ashwini More(Krishna Institute of Medical Sciences), Amey Oak(Tata Memorial Hospital), Navin Khattry(Tata Memorial Hospital), Amit D. Joshi(Harvard University), Rajendra Badwe(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Nikhil Patkar(Tata Memorial Hospital), Sujeet Kamtalwar(Tata Memorial Hospital), Pankaj Chaturvedi(Tata Memorial Hospital), Suvarna Gore(Tata Memorial Hospital), Anant Gokarn(Homi Bhabha National Institute), Preeti Chavan, Nitin Shetty(Tata Memorial Hospital), Anjali Rawat(Homi Bhabha National Institute), Sadhana Kannan(Homi Bhabha National Institute), Sumeet Mirgh(Homi Bhabha National Institute), Siddhartha Laskar(Tata Memorial Hospital), Puneeth Thatikonda(Tata Memorial Hospital)
Cited by 29
Related Papers
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694